BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10647776)

  • 1. Remarkable versatility of Smad proteins in the nucleus of transforming growth factor-beta activated cells.
    Verschueren K; Huylebroeck D
    Cytokine Growth Factor Rev; 1999; 10(3-4):187-99. PubMed ID: 10647776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta signaling by Smad proteins.
    Miyazono K
    Cytokine Growth Factor Rev; 2000; 11(1-2):15-22. PubMed ID: 10708949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transduction of the TGF-beta superfamily by Smad proteins.
    Kawabata M; Miyazono K
    J Biochem; 1999 Jan; 125(1):9-16. PubMed ID: 9880789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Smad pathway.
    Wrana JL; Attisano L
    Cytokine Growth Factor Rev; 2000; 11(1-2):5-13. PubMed ID: 10708948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Smads: transcriptional regulation and mouse models.
    Datto M; Wang XF
    Cytokine Growth Factor Rev; 2000; 11(1-2):37-48. PubMed ID: 10708951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling inputs converge on nuclear effectors in TGF-beta signaling.
    ten Dijke P; Miyazono K; Heldin CH
    Trends Biochem Sci; 2000 Feb; 25(2):64-70. PubMed ID: 10664585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
    Labbé E; Letamendia A; Attisano L
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8358-63. PubMed ID: 10890911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group 13 HOX proteins interact with the MH2 domain of R-Smads and modulate Smad transcriptional activation functions independent of HOX DNA-binding capability.
    Williams TM; Williams ME; Heaton JH; Gelehrter TD; Innis JW
    Nucleic Acids Res; 2005; 33(14):4475-84. PubMed ID: 16087734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMADs: mediators and regulators of TGF-beta signaling.
    Kretzschmar M; Massagué J
    Curr Opin Genet Dev; 1998 Feb; 8(1):103-11. PubMed ID: 9529613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional conservation of Schistosoma mansoni Smads in TGF-beta signaling.
    Beall MJ; McGonigle S; Pearce EJ
    Mol Biochem Parasitol; 2000 Nov; 111(1):131-42. PubMed ID: 11087923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta-induced transcription of the Alzheimer beta-amyloid precursor protein gene involves interaction between the CTCF-complex and Smads.
    Burton T; Liang B; Dibrov A; Amara F
    Biochem Biophys Res Commun; 2002 Jul; 295(3):713-23. PubMed ID: 12099698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad regulation in TGF-beta signal transduction.
    Moustakas A; Souchelnytskyi S; Heldin CH
    J Cell Sci; 2001 Dec; 114(Pt 24):4359-69. PubMed ID: 11792802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein.
    Stroschein SL; Wang W; Zhou S; Zhou Q; Luo K
    Science; 1999 Oct; 286(5440):771-4. PubMed ID: 10531062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
    Xu J; Attisano L
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcriptional role of Smads and FAST (FoxH1) in TGFbeta and activin signalling.
    Attisano L; Silvestri C; Izzi L; Labbé E
    Mol Cell Endocrinol; 2001 Jun; 180(1-2):3-11. PubMed ID: 11451566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling.
    Sano Y; Harada J; Tashiro S; Gotoh-Mandeville R; Maekawa T; Ishii S
    J Biol Chem; 1999 Mar; 274(13):8949-57. PubMed ID: 10085140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two major Smad pathways in TGF-beta superfamily signalling.
    Miyazawa K; Shinozaki M; Hara T; Furuya T; Miyazono K
    Genes Cells; 2002 Dec; 7(12):1191-204. PubMed ID: 12485160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.